Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.52

-8.7%

Jan 23 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (7423)	12/9/2002 12:50:05 AM
From: BulbaMan	Read Replies (1) of 52153

Bcl2 is a target of Genta's (GNTA) antisense cancer drug, Genasense. (Full disclosure: my cousin was one of the developers of GNTA's drug and I own a few shares.) Does anyone know of other companies testing Bcl2 antagonists? Does anyone else follow GNTA?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next